Gene expression profiles differed between the two models, and Tet2-knockout HSPCs had decreased levels of lineage specifiers Gata2 and Hoxa9. These findings suggest that TET2 mutations lead to different hematological malignancies that may depend on the catalytic activity of TET2 (Ito et al., 2019a). This evidence concerns the gene TET2 and hematologic disorder.